机构:[1]Department of Urology, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029临床科室泌尿外科首都医科大学附属安贞医院[2]Department of Clinical Laboratory, Tong Ren Hospital, Shanghai JiaoTong University School of Medicine, Shanghai 200233, P.R. China[3]Department of Genitourinary Medical Oncology, Cancer Medicine, MD Anderson Cancer Center, The University of Texas, Houston, TX 77030[4]Department of Anatomy and Cell Biology, Brody School of Medicine, East Carolina University, Greenville, NC 27834, USA[5]Department of Endocrinology, Beijing Jishuitan Hospital, The 4th Medical College of Peking University, Beijing 100035, P.R. China
Hypoxia-inducible factor-1 alpha (HIF-1 alpha) is known to play crucial roles in tumor radioresistance; however, the molecular mechanisms responsible for the promotion of tumor radioresistance by HIF-1 alpha remain unclear beta-catenin is known to be involved in the metastatic potential of prostate cancer (PCa). In this study, to investigate the role of HIF-1 alpha and beta-catenin in the radioresistance of PCa, two PCa cell lines, LNCaP and C4-2B, were grouped as follows: Negative control (no treatment), HIF-1 alpha overexpression group (transfected with HIF-1 alpha overexpression plasmid) and beta-catenin silenced group (transfected with HIF-1 alpha plasmids and beta-catenin-shRNA). Cell proliferation, cell cycle, cell invasion and radiosensitivity were examined under normal or hypoxic conditions. In addition, radiosensitivity was examined in two mouse PCa models (the LNCaP orthotopic BALB/c-nu mice model and the C4-2B subcutaneous SCID mice model). Our results revealed that in both the LNCaP and C4-2B cells, transfection with HIF-1 alpha overexpression plasmid led to an enhanced beta-catenin nuclear translocation, while beta-catenin silencing inhibited beta-catenin nuclear translocation. The enhanced beta-catenin nuclear translocation induced by HIF-1 alpha overexpression resulted in an enhanced cell proliferation and cell invasion, an altered cell cycle distribution, decreased apoptosis, and improved non-homologous end joining (NHEJ) repair under normal and irradiation conditions. Similar results were observed in the animal models. HIF-1 alpha overexpression enhanced beta-catenin nuclear translocation, which led to the activation of the beta-catenin/NHEJ signaling pathway and increased cell proliferation, cell invasion and DNA repair. These results thus suggest that HIF-1 alpha overexpression promotes the radioresistance of PCa cells.
基金:
National Natural Science Foundation of ChinaNational Natural Science Foundation of China [30700968, 81372858]; High Level Backbone Doctor Training Project of Beijing Health System [2015-3-054]
第一作者机构:[1]Department of Urology, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029[*1]Department of Urology, Beijing Anzhen Hospital, Capital Medical University, 2 Anzhenli Street, Chaoyang, Beijing 100029, P.R. China
通讯作者:
通讯机构:[1]Department of Urology, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029[5]Department of Endocrinology, Beijing Jishuitan Hospital, The 4th Medical College of Peking University, Beijing 100035, P.R. China[*1]Department of Urology, Beijing Anzhen Hospital, Capital Medical University, 2 Anzhenli Street, Chaoyang, Beijing 100029, P.R. China[*2]Department of Endocrinology, Beijing Jishuitan Hospital, The 4th Medical College of Peking University, 31 Xinjiekou East Street, Xicheng, Beijing 100035, P.R. China
推荐引用方式(GB/T 7714):
YONG LUO,MINGCHUAN LI,XUEMEI ZUO,et al.beta-catenin nuclear translocation induced by HIF-1 alpha overexpression leads to the radioresistance of prostate cancer[J].INTERNATIONAL JOURNAL OF ONCOLOGY.2018,52(6):1827-1840.doi:10.3892/ijo.2018.4368.
APA:
YONG LUO,MINGCHUAN LI,XUEMEI ZUO,SPYRIDON P. BASOURAKOS,JIAO ZHANG...&LING LAN.(2018).beta-catenin nuclear translocation induced by HIF-1 alpha overexpression leads to the radioresistance of prostate cancer.INTERNATIONAL JOURNAL OF ONCOLOGY,52,(6)
MLA:
YONG LUO,et al."beta-catenin nuclear translocation induced by HIF-1 alpha overexpression leads to the radioresistance of prostate cancer".INTERNATIONAL JOURNAL OF ONCOLOGY 52..6(2018):1827-1840